longact
inject
antipsychot
treatment
pandem
new
challeng
nonadher
import
factor
therapeut
failur
frequent
correl
diseas
progress
phenomenon
common
diseas
requir
chronic
treatment
cardiovascular
metabol
degen
etc
timmerman
et
al
case
mental
ill
schizophrenia
particular
nonadher
total
partial
reach
case
rather
rule
except
kane
et
al
dobber
et
al
kishimoto
et
al
medic
nonadher
associ
poor
outcom
hospit
readmiss
increas
cost
care
schizophrenia
wintonbrown
et
al
haddad
et
al
poor
medic
adher
multifactori
caus
lack
insight
individu
want
treat
hesh
consid
himselfherself
ill
persist
psychot
symptom
contrast
cognit
deficit
caus
relat
evolut
diseas
import
factor
individu
motiv
take
medic
lacro
et
al
strong
evid
superior
longact
inject
antipsychot
lai
oral
antipsychot
oa
relaps
prevent
reduc
mortal
schizophrenia
demonstr
mani
studi
taipal
et
al
lai
shown
effect
person
year
age
avoid
treatment
abandon
lai
determin
frequent
remiss
recoveri
oa
kane
et
al
effici
proven
prevent
relaps
also
cataton
form
ifteni
teodorescu
expert
consid
lai
introduc
earli
possibl
better
outcom
schizophrenia
stahl
despit
proven
effect
favor
costbenefit
ratio
lai
still
underus
worldwid
due
differ
reason
includ
econom
high
cost
mistrust
fear
stigma
outdat
concept
taylor
et
al
part
patient
refus
relat
particular
mode
administr
inject
control
treatment
feel
longer
decid
administr
protocol
special
center
post
inject
monitor
case
olanzapin
pamoat
etc
yeo
et
al
new
restrict
limit
prescript
administr
caus
pandem
ad
order
limit
possibl
contamin
author
mani
countri
includ
romania
recommend
limit
restrict
access
hospit
remain
strictli
intend
emerg
gener
practition
also
psychiatrist
limit
number
interact
patient
start
difficult
process
onlin
consult
addit
benefit
issu
regard
ethic
confidenti
access
etc
present
onlin
consult
captur
mani
aspect
psychiatr
patholog
often
imposs
case
low
incom
rural
isol
area
delay
suppli
pharmaci
caus
restrict
cancel
export
medicin
sanitari
equip
context
anoth
barrier
result
signific
number
patient
schizophrenia
soon
undergo
treatment
less
expens
easytoobtain
manag
oral
antipsychot
psychiatr
set
public
hospit
bed
acut
patient
number
lai
prescript
decreas
dramat
risperidon
lai
olanzapin
lai
decemb
march
tabl
switch
lai
oa
request
patient
caregiv
reduc
number
trip
pharmaci
medic
offic
public
mental
health
center
form
intramuscular
administr
manufactur
expert
recommend
treatment
done
special
medic
personnel
physician
nurs
center
experi
avoid
problem
administr
home
recommend
human
natur
anxieti
relat
uniqu
phenomenon
last
hundr
year
ad
conspiraci
theori
media
major
impact
patient
schizophrenia
probabl
see
come
day
week
mani
patient
clinic
remiss
switch
lai
oa
futur
mirrorimag
studi
show
consequ
switch
effect
size
directli
proport
durat
pandem
restrict
impos
noon
anticip
durat
pandem
situat
prolong
prevent
relaps
dramat
consequ
especi
patient
undergo
lai
year
experienc
relaps
long
time
even
consid
cure
would
best
standard
care
situat
propos
measur
increas
dose
delay
next
inject
administr
pharmacist
famili
member
impos
import
risk
stress
pain
superfici
profound
inject
inadequ
site
inject
deltoid
gluteal
etc
must
continu
advoc
improv
access
longact
antipsychot
peopl
previou
nonadher
well
young
patient
earli
stage
schizophrenia
even
difficult
period
none
none
author
conflict
report
